Skip to main content
Veterinary Medicines

B-19 CZV OFTALMICA

Authorised
  • Brucella abortus, strain B-19, Live

Product identification

Medicine name:
B-19 CZV OFTALMICA
Active substance:
  • Brucella abortus, strain B-19, Live
Target species:
  • Cattle
Route of administration:
  • Ocular use

Product details

Active substance and strength:
  • Brucella abortus, strain B-19, Live
    9.00
    Colony forming unit
    /
    1.00
    Dose
Pharmaceutical form:
  • Eye drops, powder and solvent for suspension
Withdrawal period by route of administration:
  • Ocular use
    • Cattle
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI02AE
Authorisation status:
  • Valid
Authorised in:
  • Spain
Available in:
  • Spain
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • CZ Vaccines S.A.U.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Cz Veterinaria S.A.
Responsible authority:
  • Spanish Agency For Medicines And Health Products
Authorisation number:
  • 3593 ESP
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 9/11/2022

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 9/11/2022

Labelling

This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 9/11/2022

es-puar-b-19-czv-oftalmica-es.pdf

Spanish (PDF)
Published on: 9/11/2022
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."